Literature DB >> 16389111

New treatments for AMD.

Richard Spaide.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16389111     DOI： 10.1016/j.ophtha.2005.10.023

Source DB:  PubMed          Journal:  Ophthalmology        ISSN： 0161-6420            Impact factor:   12.079


× No keyword cloud information.
  7 in total

1.  Intravitreal use of bevacizumab (Avastin) for choroidal neovascularization due to ARMD: a preliminary multifocal-ERG and OCT study. Multifocal-ERG after use of bevacizumab in ARMD.

Authors:  Marilita M Moschos; Dimitrios Brouzas; Michael Apostolopoulos; Chrysanthi Koutsandrea; Eleni Loukianou; Michael Moschos
Journal:  Doc Ophthalmol       Date:  2007-01-10       Impact factor: 2.379

2.  The EFFEct of HESA-A (natural drug) on visual acuity in age related macular degeneration: a randomized double blind controlled clinical trial.

Authors:  Amrollah Ahmadi; Heshmatollah Ghanbari; Masoud Soheilian; Mohsen Naseri
Journal:  Afr J Tradit Complement Altern Med       Date:  2009-07-03

3.  Potential bias in ophthalmic pharmaceutical clinical trials.

Authors:  Paul Varner
Journal:  Clin Ophthalmol       Date:  2008-06

4.  Short-term Outcomes of Saffron Supplementation in Patients with Age-related Macular Degeneration: A Double-blind, Placebo-controlled, Randomized Trial.

Authors:  Alireza Lashay; Gholamreza Sadough; Elham Ashrafi; Mohammadreza Lashay; Morteza Movassat; Shahin Akhondzadeh
Journal:  Med Hypothesis Discov Innov Ophthalmol       Date:  2016

5.  Intravitreal Bevacizumab versus Combined Bevacizumab and Triamcinolone Acetonide for Neovascular Age-Related Macular Degeneration.

Authors:  Mohammad Riazi-Esfahani; Hamid Ahmadieh; Hooshang Faghihi; Niloofar Piri; Ramin Taei; Reza Karkhaneh; Zahra Alami-Harandi; Alireza Lashay; Ahmad Mirshahi; Mehdi Nili-Ahmadabadi; Masoud Soheilian; Masoumeh Sanagou
Journal:  J Ophthalmic Vis Res       Date:  2008-04

6.  Retinal pigment epithelium culture;a potential source of retinal stem cells.

Authors:  Hassan Akrami; Zahra-Soheila Soheili; Keynoush Khalooghi; Hamid Ahmadieh; Mojgan Rezaie-Kanavi; Shahram Samiei; Malihe Davari; Shima Ghaderi; Fatemeh Sanie-Jahromi
Journal:  J Ophthalmic Vis Res       Date:  2009-07

7.  Recombinant anti-vascular endothelial growth factor fusion protein efficiently suppresses choridal neovasularization in monkeys.

Authors:  Ming Zhang; Junjun Zhang; Mi Yan; Hong Li; Chun Yang; Dechao Yu
Journal:  Mol Vis       Date:  2008-01-10       Impact factor: 2.367
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.